Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa

Experimental Eye Research

Volumn 87, Issue 3, 2008, Pages 197-207

  Guerin, K ^a   Gregory Evans, C Y ^b   Hodges, M D ^b   Moosajee, M ^b   Mackay, D S ^b   Gregory Evans, K ^b,c   Flannery, John G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c WESTERN EYE HOSPITAL   (United Kingdom)

Author keywords

gentamicin; premature stop codon; Rd12; retinal degeneration; retinitis pigmentosa; S334ter

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC G 418; GENTAMICIN; ISOMERASE; LUCIFERASE; RHODOPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CODON; CONTROLLED STUDY; DRUG INHIBITION; ELECTRORETINOGRAPHY; ENZYME ASSAY; MOUSE; MUTATION; NONHUMAN; PERINATAL PERIOD; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA DEGENERATION; RETINITIS PIGMENTOSA;

AMINOGLYCOSIDES; ANIMALS; CARRIER PROTEINS; CODON, NONSENSE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTRORETINOGRAPHY; EYE PROTEINS; FLUORESCENT DYES; GENTAMICINS; MICE; MICE, MUTANT STRAINS; RATS; RATS, TRANSGENIC; RETINA; RETINITIS PIGMENTOSA; RHODOPSIN; XANTHENES;

EID: 50849094851     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.05.016     Document Type: Article

References (56)

1. Adato A., Weil D., Kalinski H., Pel-Or Y., Ayadi H., Petit C., Korostishevsky M., and Bonne-Tamir B. Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins. Am. J. Hum. Genet. 61 (1997) 813-821
2. Ainsworth C. Nonsense mutations: running the red light. Nature 438 (2005) 726-728
3. Arakawa M., Shiozuka M., Nakayama Y., Hara T., Hamada M., Kondo S., Ikeda D., Takahashi Y., Sawa R., Nonomura Y., Sheykholeslami K., Kondo K., Kaga K., Kitamura T., Suzuki-Miyagoe Y., Takeda S., and Matsuda R. Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice. J. Biochem. 134 (2003) 751-758
4. Barton-Davis E.R., Cordier L., Shoturma D.I., Leland S.E., and Sweeney H.L. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J. Clin. Invest. 104 (1999) 375-381
5. Behm-Ansmant I., Kashima I., Rehwinkel J., Saulière J., Wittkopp N., and Izaurralde E. mRNA quality control: an ancient machinery recognizes and degrades mRNAs with nonsense codons. FEBS Lett. 581 (2007) 2845-2853
6. Bidou L., Hatin I., Perez N., Allamand V., Panthier J.J., and Rousset J.P. Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment. Gene Ther. 11 (2004) 619-627
7. Chen J., Makino C.L., Peachey N.S., Baylor D.A., and Simon M.I. Mechanisms of rhodopsin inactivation in vivo as revealed by a COOH-terminal truncation mutant. Science 267 (1995) 374-377
8. Cooper D.N., Ball E.V., Stenson P.D., Phillips A.D., Howells K., and Mort M.E. The Human Gene Mutation Database (2007). http://www.hgmd.cf.ac.uk
9. Daiger S., Rossiter B., Greenberg J., Christoffels A., and Wu H. RetNet, the Retinal Information Network (2007). http://www.sph.uth.tmc.edu/RetNet
10. Du M., Jones J.R., Lanier J., Keeling K.M., Lindsey J.R., Tousson A., Bebök Z., Whitsett J.A., Dey C.R., Colledge W.H., Evans M.J., Sorscher E.J., and Bedwell D.M. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene. J. Mol. Med. 80 (2002) 595-604
11. Dunant P., Walter M.C., Karpati G., and Lochmuller H. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle. Muscle Nerve 27 (2003) 624-627
12. Fabre, J., Rudhardt, M., Blanchard, P., Regamey, C., Chauvin, P., 1976. Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int. 10, 444-449.
13. Farber D., Flannery J., and Bowes-Rickman C. The rd mouse story: seventy years of research on an animal model of inherited retinal degeneration. Prog. Retina Eye Res. 13 (1994) 31-64
14. Fiscella R.G., Gieser J., Phillpotts B., Gilmartin C., Labib S., Cwik M.J., Solomon M.J., and Shapiro M.J. Intraocular penetration of gentamicin after once-daily aminoglycoside dosing. Retina 18 (1998) 339-342
15. Friedman J.S., Chang B., Kannabiran C., Chakarova C., Singh H.P., Jalali S., Hawes N.L., Branham K., Othman M., Filippova E., Thompson D.A., Webster A.R., Andréasson S., Jacobson S.G., Bhattacharya S.S., Heckenlively J.R., and Swaroop A. Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration. Am. J. Med. Genet. 79 (2006) 1059-1070
16. Frischmeyer P.A., and Dietz H.C. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 8 (1999) 1893-1900
17. Grayson C., Chapple J.P., Willison K.R., Webster A.R., Hardcastle A.J., and Cheetham M.E. In vitro analysis of aminoglycoside therapy for the Arg120stop nonsense mutation in RP2 patients. J. Med. Genet. 39 (2002) 62-67
18. Green E.S., Menz M.D., LaVail M.M., and Flannery J.G. Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa. Invest. Ophthal. Vis. Sci. 41 (2000) 1546-1553
19. Hein L.K., Bawden M., Muller V.J., Sillence D., Hopwood J.J., and Brooks D.A. Alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients. J. Mol. Biol. 338 (2004) 453-462
20. Holbrook J.A., Neu-Yilik G., Hentze M.W., and Kulozik A.E. Nonsense-mediated decay approaches the clinic. Nat. Genet. 36 (2004) 801-808
21. Hong D.H., Pawlyk B.S., Adamian M., and Li T. Dominant, gain-of-function mutant produced by truncation of RPGR. Invest. Ophthal. Vis. Sci. 45 (2004) 36-41
22. Howard M.T., Shirts B.H., Petros L.M., Flanigan K.M., Gesteland R.F., and Atkins J.F. Sequence specificity of aminoglycoside-induced stop codon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann. Neurol. 48 (2000) 164-169
23. Howard M.T., Anderson C.B., Fass U., Khatri S., Gesteland R.F., Atkins J.F., and Flanigan K.M. Readthrough of dystrophin stop codon mutations induced by aminoglycosides. Ann. Neurol. 55 (2004) 422-426
24. Jimenez A.J., Garcia-Fernandez J.M., Gonzalez B., and Foster R.G. The spatio-temporal pattern of photoreceptor degeneration in the aged rd/rd mouse retina. Cell Tissue Res. 284 (1996) 193-202
25. Karatas Y., Secilmis M.A., Karayaylali I., Doran F., Singirik E., Sagliker Y., and Dikmen A. Effect of tempol (4-hydroxy tempo) on gentamicin-induced nephrotoxicity in rats. Fundam. Clin. Pharmacol. 18 (2004) 79-83
26. Keeling K.M., Brooks D.A., Hopwood J.J., Li P., Thompson J.N., and Bedwell D.M. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum. Mol. Genet. 10 (2001) 291-299
27. Krawczak M., Ball E.V., Fenton I., Stenson P.D., Abeysinghe S., Thomas N., and Cooper D.N. Human gene mutation database-a biomedical information and research resource. Hum. Mutat. 15 (2000) 45-51
28. LaVail M.M., Gorrin G.M., and Repaci M.A. Strain differences in sensitivity to light-induced photoreceptor degeneration in albino mice. Curr. Eye Res. 6 (1987) 825-834
29. Lee E.S., Burnside B., and Flannery J.G. Characterization of peripherin/rds and rom-1 transport in rod photoreceptors of transgenic and knockout animals. Invest. Ophthal. Vis. Sci. 47 (2006) 2150-2160
30. Leroy B.P., Aragon-Martin J.A., Weston M.D., Bessant D.A., Willis C., Webster A.R., Bird A.C., Kimberling W.J., Payne A.M., and Bhattacharya S.S. Spectrum of mutations in USH2A in British patients with Usher syndrome type II. Exp. Eye Res. 72 (2001) 503-509
31. Linde L., Boelz S., Nissim-Rafinia M., Oren Y.S., Wilschanski M., Yaacov Y., Virgilis D., Neu-Yilik G., Kulozik A.E., Kerem E., and Kerem B. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J. Clin. Invest. 117 (2007) 683-692
32. Lyeford-Pike S., Vogelheim C., Chu E., Della Santina C.C., and Carey J.P. Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration. J. Assoc. Res. Otolarygol. 8 (2007) 497-508
33. Mankin A.S., and Liebman S.W. Baby, don't stop!. Nat. Genet. 23 (1999) 8-10
34. Manuvakhova M., Keeling K., and Bedwell D.M. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA 6 (2000) 1044-1055
35. Maquat L.E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat. Rev. Mol. Cell Biol. 5 (2004) 89-99
36. Moehle E.A., Rock J.M., Lee Y.L., Jouvenot Y., DeKelver R.C., Gregory P.D., Urnov F.D., and Holmes M.C. Targeted gene addition into a specified location in the human genome using zinc finger nucleases. Proc. Natl. Acad. Sci. USA 104 (2007) 3055-3060
37. Nagai J., and Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab. Pharmacokinet 19 (2004) 159-170
38. Nudelman I., Rebibo-Sabbah A., Shallom-Shezifi D., Hainrichson M., Stahl I., Ben-Yosef T., and Baasov T. Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations. Bioorg. Med. Chem. Lett. 16 (2006) 6310-6315
39. Pang J.J., Chang B., Hawes N.L., Hurd R.E., Davisson M.T., Li J., Noorwez S.M., Malhotra R., McDowell J.H., Kaushal S., Hauswirth W.W., Nusinowitz S., Thompson D.A., and Heckenlively J.R. Retinal degeneration (rd12): a new, spontaneously arising mouse model for Leber congenital amaurosis (LCA). Mol. Vis 11 (2005) 152-162
40. Paskowitz D.M., Donohue-Rolfe K.M., Yang H., Yasumura D., Matthes M.T., Hosseini K., Graybeal C.M., Nune G., Zarbin M.A., LaVail M.M., and Duncan J.L. Neurotrophic factors minimize the retinal toxicity of verteporfin photodynamic therapy. Invest. Ophthal. Vis. Sci. 48 (2007) 430-437
41. Pinotti M., Rizzotto L., Pinton P., Ferraresi P., Chuansumrit A., Charoenkwan P., Marchetti G., Rizzuto R., Marian G., and Bernardi F. Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII. J. Thromb. Haemost. 4 (2006) 1308-1314
42. Pittler S.J., Coan P., Kontzen P.L., Allen D., Bedwell D., and Kraft T.W. Aminoglycosides partially restore photoreceptor function in the rd1 mouse. E-Abstract 2837. Available at. Invest. Ophthal. Vis. Sci. 43 (2001). http://www.iovs.org
43. Politano L., Nigro G., Nigro V., Piluso G., Papparella S., Paciello O., and Comi L.I. Gentamicin administration in Duchenne patients with a premature stop codon. Preliminary results. Acta. Myol. 22 (2003) 15-21
44. Sangkuhl K., Schulz A., Rompler H., Yun J., Wess J., and Schoneberg T. Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 receptor gene in vitro and in vivo. Hum. Mol. Genet. 13 (2004) 893-903
45. Sénéchal A., Humbert G., Surget M.O., Bazalgette C., Bazalgette C., Arnaud B., Arndt C., Laurent E., Brabet P., and Hamel C.P. Screening genes of the retinoid metabolism: novel LRAT mutation in leber congenital amaurosis. Am. J. Ophthalmol. 142 (2006) 702-704
46. Sleat D.E., Sohar I., Gin R.M., and Lobel P. Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis. Eur. J. Paediatr. Neurol. 5 (2001) 57-62
47. Steinberg R.H., Flannery R.G., and Naash M. Transgenic rat models of inherited retinal degeneration caused by mutant opsin genes. E-Abstract 698. Available at. Invest. Ophthal. Vis. Sci. 37 (1996). http://www.iovs.org
48. Urnov F.D., Miller J.C., Lee Y.L., Beausejour C.M., Rock J.M., Augustus S., Jamieson A.C., Porteus M.H., Gregory P.D., and Holmes M.C. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435 (2005) 646-651
49. Vandewalle A., Farman N., Morin J.P., Fillastre J.P., Hatt P.Y., and Bonvalet J.P. Gentamicin incorporation along the nephron: autoradiographic study on isolated tubules. Kidney Int. 19 (1981) 529-539
50. Verbraeken H., Verstraete A., Van de Velde E., and Verschraegen G. Penetration of gentamicin and ofloxacin in human vitreos after systemic administration. Graefes Arch. Clin. Exp. Ophthalmol. 234 Suppl. 1 (1996) S59-S65
51. Wagner K.R., Hamed S., Hadley D.W., Gropman A.L., Burstein A.H., Escolar D.M., Hoffman E.P., and Fischbeck K.H. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann. Neurol. 49 (2001) 706-711
52. Watanabe A., Nagai J., Adachi Y., Katsube T., Kitahara Y., Murakami T., and Takano M. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists. J. Control Release 95 (2004) 423-433
53. Welch E.M., Barton E.R., Zhou J., Tomizawa Y., Friesen W.J., Trifillis P., Paushkin S., Patel M., Trotta C.R., Hwang S., Wilde R.G., Karp G., Takasugi J., Chen G., Jones S., Ren H., Moon Y.C., Corson D., Turpoff A.A., Campbell J.A., Conn M.M., Khan A., Almstead N.G., Hedrick J., Mollin A., Risher N., Weetall M., Yeh S., Branstrom A.A., Colacino J.M., Babiak J., Ju W.D., Hirawat S., Northcutt V.J., Miller L.L., Spatrick P., He F., Kawana M., Feng H., Jacobson A., Peltz S.W., and Sweeney H.L. PTC124 targets genetic disorders caused by nonsense mutations. Nature 477 (2007) 87-91
54. Wilschanski M., Yahav Y., Yaacov Y., Blau H., Bentur L., Rivlin J., Aviram M., Bdolah-Abram T., Bebok Z., Shushi L., Kerem B., and Karem E. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N. Engl. J. Med. 349 (2003) 1433-1441
55. Xi B., Guan F., and Lawrence D.S. Enhanced production of functional proteins from defective genes. J. Am. Chem. Soc. 126 (2004) 5660-5661
56. Zhang Q., Acland G.M., Wu W.X., Johnson J.L., Pearce-Kelling S., Tulloch B., Vervoort R., Wright A.F., and Aguirre G.D. Different RPGR exon ORF15 mutations in Canids provide insights into photoreceptor cell degeneration. Hum. Mol. Genet. 11 (2002) 993-1003